Dysembryoplastic neuroepithelial tumor

WikiDoc Resources for Dysembryoplastic neuroepithelial tumor
Articles
Most recent articles on Dysembryoplastic neuroepithelial tumor Most cited articles on Dysembryoplastic neuroepithelial tumor Review articles on Dysembryoplastic neuroepithelial tumor Articles on Dysembryoplastic neuroepithelial tumor in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Dysembryoplastic neuroepithelial tumor Images of Dysembryoplastic neuroepithelial tumor Photos of Dysembryoplastic neuroepithelial tumor Podcasts & MP3s on Dysembryoplastic neuroepithelial tumor Videos on Dysembryoplastic neuroepithelial tumor
Evidence Based Medicine
Cochrane Collaboration on Dysembryoplastic neuroepithelial tumor Bandolier on Dysembryoplastic neuroepithelial tumor TRIP on Dysembryoplastic neuroepithelial tumor
Clinical Trials
Ongoing Trials on Dysembryoplastic neuroepithelial tumor at Clinical Trials.gov Trial results on Dysembryoplastic neuroepithelial tumor Clinical Trials on Dysembryoplastic neuroepithelial tumor at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Dysembryoplastic neuroepithelial tumor NICE Guidance on Dysembryoplastic neuroepithelial tumor NHS PRODIGY Guidance FDA on Dysembryoplastic neuroepithelial tumor CDC on Dysembryoplastic neuroepithelial tumor
Books
Books on Dysembryoplastic neuroepithelial tumor
News
Dysembryoplastic neuroepithelial tumor in the news Be alerted to news on Dysembryoplastic neuroepithelial tumor News trends on Dysembryoplastic neuroepithelial tumor
Commentary
Blogs on Dysembryoplastic neuroepithelial tumor
Definitions
Definitions of Dysembryoplastic neuroepithelial tumor
Patient Resources / Community
Patient resources on Dysembryoplastic neuroepithelial tumor Discussion groups on Dysembryoplastic neuroepithelial tumor Patient Handouts on Dysembryoplastic neuroepithelial tumor Directions to Hospitals Treating Dysembryoplastic neuroepithelial tumor Risk calculators and risk factors for Dysembryoplastic neuroepithelial tumor
Healthcare Provider Resources
Symptoms of Dysembryoplastic neuroepithelial tumor Causes & Risk Factors for Dysembryoplastic neuroepithelial tumor Diagnostic studies for Dysembryoplastic neuroepithelial tumor Treatment of Dysembryoplastic neuroepithelial tumor
Continuing Medical Education (CME)
CME Programs on Dysembryoplastic neuroepithelial tumor
International
Dysembryoplastic neuroepithelial tumor en Espanol Dysembryoplastic neuroepithelial tumor en Francais
Business
Dysembryoplastic neuroepithelial tumor in the Marketplace Patents on Dysembryoplastic neuroepithelial tumor
Experimental / Informatics
List of terms related to Dysembryoplastic neuroepithelial tumor

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Your Name

Synonyms and keywords: Synonym 1; Synonym 2; Synonym 3

Historical Perspective

• Dysembryoplastic neuroepithelial tumor was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
• In [year], [gene] mutations were first identified in the pathogenesis of dysembryoplastic neuroepithelial tumor.
• In [year], the first [discovery] was developed by [scientist] to treat/diagnose dysembryoplastic neuroepithelial tumor.

Classification

• Dysembryoplastic neuroepithelial tumor may be classified according to [classification method] into [number] subtypes/groups:

• [group1]
• [group2]
• [group3]

• Other variants of dysembryoplastic neuroepithelial tumor include [disease subtype 1], [disease subtype 2], and [disease subtype 3].

Pathophysiology

• The pathogenesis of dysembryoplastic neuroepithelial tumor is characterized by [feature1], [feature2], and [feature3].
• The [gene name] gene/Mutation in [gene name] has been associated with the development of dysembryoplastic neuroepithelial tumor, involving the [molecular pathway] pathway.
• On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of dysembryoplastic neuroepithelial tumor.
• On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of dysembryoplastic neuroepithelial tumor.

Causes

• Dysembryoplastic neuroepithelial tumor may be caused by either [cause1], [cause2], or [cause3].
• Dysembryoplastic neuroepithelial tumor is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
• There are no established causes for dysembryoplastic neuroepithelial tumor.

Differentiating dysembryoplastic neuroepithelial tumor from other Diseases

• Dysembryoplastic neuroepithelial tumor must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:

• [Differential dx1]
• [Differential dx2]
• [Differential dx3]

Epidemiology and Demographics

• The prevalence of dysembryoplastic neuroepithelial tumor is approximately [number or range] per 100,000 individuals worldwide.
• In [year], the incidence of dysembryoplastic neuroepithelial tumor was estimated to be [number or range] cases per 100,000 individuals in [location].

Age

• Patients of all age groups may develop dysembryoplastic neuroepithelial tumor.

• Dysembryoplastic neuroepithelial tumor is more commonly observed among patients aged [age range] years old.
• Dysembryoplastic neuroepithelial tumor is more commonly observed among [elderly patients/young patients/children].

Gender

• Dysembryoplastic neuroepithelial tumor affects men and women equally.

• [Gender 1] are more commonly affected with dysembryoplastic neuroepithelial tumor than [gender 2].
• The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

• There is no racial predilection for dysembryoplastic neuroepithelial tumor.

• Dysembryoplastic neuroepithelial tumor usually affects individuals of the [race 1] race.
• [Race 2] individuals are less likely to develop dysembryoplastic neuroepithelial tumor.

Risk Factors

• Common risk factors in the development of dysembryoplastic neuroepithelial tumor are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

• The majority of patients with dysembryoplastic neuroepithelial tumor remain asymptomatic for [duration/years].
• Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
• If left untreated, [#%] of patients with dysembryoplastic neuroepithelial tumor may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
• Common complications of dysembryoplastic neuroepithelial tumor include [complication 1], [complication 2], and [complication 3].
• Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with dysembryoplastic neuroepithelial tumor is approximately [#%].

Diagnosis

Diagnostic Criteria

• The diagnosis of dysembryoplastic neuroepithelial tumor is made when at least [number] of the following [number] diagnostic criteria are met:

• [criterion 1]
• [criterion 2]
• [criterion 3]
• [criterion 4]

Symptoms

• Dysembryoplastic neuroepithelial tumor is usually asymptomatic.
• Symptoms of dysembryoplastic neuroepithelial tumor may include the following:

• [symptom 1]
• [symptom 2]
• [symptom 3]
• [symptom 4]
• [symptom 5]
• [symptom 6]

Physical Examination

• Patients with dysembryoplastic neuroepithelial tumor usually appear [general appearance].
• Physical examination may be remarkable for:

• [finding 1]
• [finding 2]
• [finding 3]
• [finding 4]
• [finding 5]
• [finding 6]

Laboratory Findings

• There are no specific laboratory findings associated with dysembryoplastic neuroepithelial tumor.

• A [positive/negative] [test name] is diagnostic of dysembryoplastic neuroepithelial tumor.
• An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of dysembryoplastic neuroepithelial tumor.
• Other laboratory findings consistent with the diagnosis of dysembryoplastic neuroepithelial tumor include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

• There are no [imaging study] findings associated with dysembryoplastic neuroepithelial tumor.

• [Imaging study 1] is the imaging modality of choice for dysembryoplastic neuroepithelial tumor.
• On [imaging study 1], dysembryoplastic neuroepithelial tumor is characterized by [finding 1], [finding 2], and [finding 3].
• [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

• Dysembryoplastic neuroepithelial tumor may also be diagnosed using [diagnostic study name].
• Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

• There is no treatment for dysembryoplastic neuroepithelial tumor; the mainstay of therapy is supportive care.

• The mainstay of therapy for dysembryoplastic neuroepithelial tumor is [medical therapy 1] and [medical therapy 2].
• [Medical therapy 1] acts by [mechanism of action1].
• Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

• Surgery is the mainstay of therapy for dysembryoplastic neuroepithelial tumor.
• [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of dysembryoplastic neuroepithelial tumor.
• [Surgical procedure] can only be performed for patients with [disease stage] dysembryoplastic neuroepithelial tumor.

Prevention

• There are no primary preventive measures available for dysembryoplastic neuroepithelial tumor.

• Effective measures for the primary prevention of dysembryoplastic neuroepithelial tumor include [measure1], [measure2], and [measure3].

• Once diagnosed and successfully treated, patients with dysembryoplastic neuroepithelial tumor are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].